在再生医学中平衡组织和肿瘤形成。
Balancing tissue and tumor formation in regenerative medicine.
机构信息
Office of Cellular, Tissue, and Gene Therapies, Center for Biologics Evaluation and Research, FDA, Rockville, MD 20852, USA.
出版信息
Sci Transl Med. 2012 Aug 15;4(147):147fs28. doi: 10.1126/scitranslmed.3003685.
PMID:22896673
Abstract
A set of general principles can guide preclinical testing strategies for evaluating the tumorigenicity of regenerative medicine products.
摘要
一套通用原则可以指导用于评估再生医学产品致瘤性的临床前测试策略。
Zotero 插件